Floater Stories: Assessing the Potential Benefits of Vitrectomy.

DVS SVO degenerative vitreous syndrome floaters vitrectomy vitreous opacities

Journal

Clinical ophthalmology (Auckland, N.Z.)

ISSN: 1177-5467

Titre abrégé: Clin Ophthalmol

Pays: New Zealand

ID NLM: 101321512

Informations de publication

Date de publication:
2024

Historique:

received: 25 03 2024

accepted: 27 05 2024

medline: 10 6 2024

pubmed: 10 6 2024

entrez: 10 6 2024

Statut: epublish

Résumé

Symptomatic vitreous opacities (SVO, "floaters") in the mobile, aging vitreous that substantially interfere with daily visual activities (DVA) constitute degenerative vitreous syndrome (DVS). DVS is best distinguished from common "nuisance" floaters by use of "floater stories" written by presenting patients describing their symptoms. Here I discuss why vitreous opacity vitrectomy, though curative, has been adopted only belatedly and is still controversial, and I describe my long-term experience with its use for this disease.

Identifiants

DOI: 10.2147/OPTH.S460876 PMID: 38855015 PMC: PMC11162631

pubmed: 38855015

doi: 10.2147/OPTH.S460876

pii: 460876

pmc: PMC11162631

doi:

Types de publication

Journal Article

Langues

eng

Pagination

1651-1654

Informations de copyright

Déclaration de conflit d'intérêts

The author reports no conflicts of interest in this work. The website referenced in the article (https://www.floaterstories.com) is sponsored by the Helen Keller Foundation as a public service. The author is President of the Foundation and assisted in development of this website.